Back the right biology
Validate targets, map disease biology, and turn multi-omics evidence into decision-ready outputs without waiting on specialist queues.
Target biology, without the wait
See how EMET supports discovery teams focused on target validation, pathway analysis, and multi-omics interpretation.
Discovery capabilities
Explore a range of sample prompts and representative outputs from EMET across the workflows below.
Target ID & Validation
I'm working on MASH (metabolic dysfunction-associated steatohepatitis). Identify the top genetically supported targets from GWAS, validate causality using Mendelian Randomization, cross-reference with CRISPR essentiality and druggability, and give me a GO/NO-GO assessment for each.
Disease Biology and Pathways
Starting from the top 200 DEGs in PIK3CA-mutant breast cancer, run pathway enrichment, build the protein interaction network, and identify the 3 most central hub proteins as potential combination therapy targets.
Plasmid & Vector Design
I want to assemble four BioBrick parts - a promoter, RBS, GFP coding sequence, and terminator - using Gibson assembly. Show me the assembly order and overlap regions as a network diagram.
Structure Based Drug Design
Predict the structure of the EGFR L858R mutant, compare it to the WT AlphaFold model, identify the structural impact at the ATP binding site, and dock osimertinib to assess binding pose changes.
Multi-omics profiling
We have a GEO dataset of NSCLC tumor vs. adjacent normal - run the full pipeline: find the top DEGs, map them to immune pathways, deconvolve the tumor microenvironment, and give me a slide-ready summary with the volcano plot and immune composition chart.
Frequently asked questions
Drug programs fail when biology is misunderstood. EMET exists to close that gap — before it closes your pipeline.
Start free trial